Hormone Replacement Therapy Is Associated with Disease Activity Improvement among Post-Menopausal Women with Inflammatory Bowel Disease
Open Access
- 23 December 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (1) , 88
Abstract
(1) Background: There are limited data available to guide clinical decision-making regarding the effects of hormone replacement therapy (HRT) in post-menopausal women with inflammatory bowel disease (IBD). In this study, we sought to characterize a population of post-menopausal women with IBD and to determine the effects of HRT on their disease activity. (2) Methods: A multicenter, retrospective, case–control cohort study of post-menopausal women with IBD was conducted. The physician global assessment (PGA) score was used to quantify disease activity. To control for the effects of menopause, IBD patients who had not undergone HRT were used as controls. (3) Results: There was a significant reduction in the frequency of PGA scores ≥2 post HRT treatment (p < 0.01). HRT treatment was associated with a 5.6× increase in the odds of post-HRT PGA score improvement compared to controls (OR 5.6; 95% CL 1.6, 19.7) in our univariate logistic regression analysis. (4) Conclusion: Post-menopausal IBD women who underwent HRT therapy showed an improvement in their disease symptoms following HRT compared to post-menopausal women without HRT therapy, who showed no change.Keywords
This publication has 12 references indexed in Scilit:
- Effects of Estrogen on the Gastrointestinal TractDigestive Diseases and Sciences, 2018
- The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity—A Cross-Sectional Cohort StudyInflammatory Bowel Diseases, 2018
- Experience of menopause in women with inflammatory bowel disease: pilot studyClimacteric, 2017
- Estradiol Has Differential Effects on Acute Colonic Inflammation in the Presence and Absence of Estrogen Receptor β ExpressionDigestive Diseases and Sciences, 2017
- Gender-related differences in irritable bowel syndrome: Potential mechanisms of sex hormonesWorld Journal of Gastroenterology, 2014
- Estrogen receptor‐β protects against colitis‐associated neoplasia in miceInternational Journal of Cancer, 2012
- Contraceptive use among women with inflammatory bowel disease: A systematic reviewContraception, 2010
- Hormonal Replacement Therapy After Menopause Is Protective of Disease Activity in Women With Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology, 2008
- Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort studyGut, 1999
- The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence studyAmerican Journal of Gastroenterology, 1998